210 related articles for article (PubMed ID: 31400703)
21. Generation of human iPS cell line IBCHi001-A from dentatorubral-pallidoluysian atrophy patient's fibroblasts.
Kozlowska E; Ciolak A; Olejniczak M; Fiszer A
Stem Cell Res; 2019 Aug; 39():101512. PubMed ID: 31374462
[TBL] [Abstract][Full Text] [Related]
22. Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons.
Jiao J; Yang Y; Shi Y; Chen J; Gao R; Fan Y; Yao H; Liao W; Sun XF; Gao S
Hum Mol Genet; 2013 Nov; 22(21):4241-52. PubMed ID: 23773995
[TBL] [Abstract][Full Text] [Related]
23. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
25. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
[TBL] [Abstract][Full Text] [Related]
26. Generation of iPSC lines (KAIMRCi003A, KAIMRCi003B) from a Saudi patient with Dravet syndrome carrying homozygous mutation in the CPLX1 gene and heterozygous mutation in SCN9A.
Alowaysi M; Al-Shehri M; Badkok A; Attas H; Aboalola D; Baadhaim M; Alzahrani H; Daghestani M; Zia A; Al-Ghamdi K; Al-Ghamdi A; Zakri S; Aouabdi S; Tegner J; Alsayegh K
Hum Cell; 2024 Mar; 37(2):502-510. PubMed ID: 38110787
[TBL] [Abstract][Full Text] [Related]
27. Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations.
Huang Z; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 Oct; 40():101549. PubMed ID: 31494449
[TBL] [Abstract][Full Text] [Related]
28. SCN1A/Na
Mantegazza M; Broccoli V
Epilepsia; 2019 Dec; 60 Suppl 3():S25-S38. PubMed ID: 31904127
[TBL] [Abstract][Full Text] [Related]
29. Channelopathy as a SUDEP Biomarker in Dravet Syndrome Patient-Derived Cardiac Myocytes.
Frasier CR; Zhang H; Offord J; Dang LT; Auerbach DS; Shi H; Chen C; Goldman AM; Eckhardt LL; Bezzerides VJ; Parent JM; Isom LL
Stem Cell Reports; 2018 Sep; 11(3):626-634. PubMed ID: 30146492
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.
Wang JW; Shi XY; Kurahashi H; Hwang SK; Ishii A; Higurashi N; Kaneko S; Hirose S;
Epilepsy Res; 2012 Dec; 102(3):195-200. PubMed ID: 23195492
[TBL] [Abstract][Full Text] [Related]
31. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
32. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
33. From focal epilepsy to Dravet syndrome--Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit.
Hoffman-Zacharska D; Szczepanik E; Terczynska I; Goszczanska-Ciuchta A; Zalewska-Miszkurka Z; Tataj R; Bal J
Neurol Neurochir Pol; 2015; 49(4):258-66. PubMed ID: 26188943
[TBL] [Abstract][Full Text] [Related]
34. On the likelihood of SCN1A microdeletions or duplications in Dravet syndrome with missense mutation.
Shi X; Wang J; Kurahashi H; Ishii A; Higurashi N; Kaneko S; Hirose S
Brain Dev; 2012 Sep; 34(8):617-9. PubMed ID: 22206733
[TBL] [Abstract][Full Text] [Related]
35. Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.
Wang Y; Zhang Y; Zhang J; Lu J; Yang C; Zhao J; Li G; Liu Z; Lei Y
Stem Cell Res; 2017 Dec; 25():22-25. PubMed ID: 29035843
[TBL] [Abstract][Full Text] [Related]
36. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
[TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
[TBL] [Abstract][Full Text] [Related]
39. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
Bayat A; Hjalgrim H; Møller RS
Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
[TBL] [Abstract][Full Text] [Related]
40. Case studies in neuroscience: a novel amino acid duplication in the NH
Angus M; Peters CH; Poburko D; Brimble E; Spelbrink EM; Ruben PC
J Neurophysiol; 2019 Nov; 122(5):1975-1980. PubMed ID: 31533007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
